McNeely T B, Coonrod J D
Department of Medicine, Veterans Affairs Medical Center, Lexington, Kentucky.
Am J Respir Cell Mol Biol. 1994 Jul;11(1):114-22. doi: 10.1165/ajrcmb.11.1.8018334.
The ability of surfactant protein A (SP-A) to aggregate and opsonize type a and b Hemophilus influenzae was investigated. Type a, but not type b, was aggregated by SP-A. Aggregation was maximal at 24 micrograms SP-A/ml and was Ca(2+)-dependent. Aggregation of type a was inhibited by D-glucosyl-BSA but not by high concentrations of monosaccharides (D-mannose, D-galactose, D-glucose, or L-fucose) or by sialic acid, purified type a capsular polysaccharide, or type IV collagen. In Western blots, 125I-labeled SP-A bound to the major outer membrane protein (putatively P2) of type a hemophilus by a Ca(2+)-dependent mechanism. This binding was competitively inhibited by excess unlabeled SP-A. 125I-labeled SP-A also bound to the major membrane protein of type b, but at less than 5% of the level observed for type a. SP-A did not bind to lipooligosaccharides of either type a or type b. SP-A increased association of type a, but not type b, hemophilus with alveolar macrophages. After opsonization with SP-A, type a hemophilus were killed by alveolar macrophages, as indicated by bactericidal assays and the release of soluble, radiolabeled products from leukocytes. It is concluded that SP-A aggregated and opsonized type a hemophilus, but not type b, possibly because SP-A bound to the P2 outer membrane protein of type a to a greater extent.
研究了表面活性蛋白A(SP-A)聚集并调理a型和b型流感嗜血杆菌的能力。SP-A能使a型流感嗜血杆菌聚集,但不能使b型聚集。聚集在SP-A浓度为24微克/毫升时达到最大值,且依赖于Ca(2+)。a型流感嗜血杆菌的聚集受到D-葡萄糖基-BSA的抑制,但不受高浓度单糖(D-甘露糖、D-半乳糖、D-葡萄糖或L-岩藻糖)、唾液酸、纯化的a型荚膜多糖或IV型胶原的抑制。在蛋白质印迹法中,125I标记的SP-A通过依赖于Ca(2+)的机制与a型流感嗜血杆菌的主要外膜蛋白(推测为P2)结合。这种结合被过量的未标记SP-A竞争性抑制。125I标记的SP-A也与b型流感嗜血杆菌的主要膜蛋白结合,但结合水平不到a型的5%。SP-A不与a型或b型的脂寡糖结合。SP-A增加了a型流感嗜血杆菌与肺泡巨噬细胞的结合,但未增加b型的结合。用SP-A调理后,a型流感嗜血杆菌被肺泡巨噬细胞杀死,杀菌试验和白细胞释放可溶性放射性标记产物表明了这一点。结论是,SP-A聚集并调理了a型流感嗜血杆菌,但未调理b型,可能是因为SP-A与a型的P2外膜蛋白结合程度更高。